Weight loss with subcutaneous semaglutide versus other glucagon-like peptide 1 receptor agonists in type 2 diabetes: a systematic review.
Stretton B, Kovoor J, Bacchi S, Chang S, Ngoi B, Murray T, Bristow TC, Heng J, Gupta A, Ovenden C, Maddern G, Thompson CH, Heilbronn L, Boyd M, Rayner C, Talley NJ, Horowtiz M.
Stretton B, et al. Among authors: bacchi s.
Intern Med J. 2023 Aug;53(8):1311-1320. doi: 10.1111/imj.16126. Epub 2023 Jun 21.
Intern Med J. 2023.
PMID: 37189293
Review.